Levodopa and Plant‐Derived Bioactive Compounds in Parkinson's Disease: Mechanisms, Efficacy, and Future Perspectives

Documenti analoghi

• Electrophysiological Alterations in the Progression of Parkinson's Disease and the Therapeutic Effect of Tetrabenazine on Rats With Levodopa‐Induced Dyskinesia
  di: Yuewei Bi, et al.
  Pubblicazione: (2025)
• Identifying Risk Factors and Constructing Predictive Models for Wearing‐Off and Dyskinesia in Chinese Patients With Parkinson's Disease on Long‐Term Levodopa Therapy
  di: Jing Zhao, et al.
  Pubblicazione: (2025)
• Reorganization of Mitochondrial Function and Architecture in Response to Plant‐Derived Alkaloids: Anatabine, Anabasine, and Nicotine, Investigated in SH ‐ SY5Y Cells and in a Cellular Model of Parkinson's Disease
  di: Dominika Malińska, et al.
  Pubblicazione: (2025)
• What We Know About TMEM175 in Parkinson's Disease
  di: Jing Wang, et al.
  Pubblicazione: (2025)
• Data‐Driven Subtypes of Parkinson Disease Based on Dopamine Responsiveness
  di: Jian‐Yong Wang, et al.
  Pubblicazione: (2025)